INVERSAGO PHARMACEUTICALS
Novo Nordisk shares drop more than 4% on disappointing obesity pill dataShares were down 4.3% at 1330 GMT, the lowest since August 8, after the company announced headline results from its trial of monlunabant, a...
- Load More